How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?
- PMID: 17627286
- DOI: 10.1038/sj.cdd.4402196
How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?
Abstract
A number of elegant studies exploring the consequences of expression of various mutant forms of p53 in mice have been published over the last years. The results and conclusions drawn from these studies often contradict results previously obtained in biochemical assays and cell biology studies, questioning their relevance for p53 function in vivo. Owing to the multitude of post-translational modifications imposed on p53, however, the in vivo validation of their relevance for proper protein function and tumour suppression is constantly lagging behind new biochemical discoveries. Nevertheless, mouse genetics presents again its enormous power. Despite being relatively slow and tedious, it has become indispensable for researchers to sort out the wheat from the chaff in an endless sea of publications on p53.
Similar articles
-
The ubiquitin-proteasome system is inhibited by p53 protein expression in human ovarian cancer cells.Cancer Lett. 2010 Aug 1;294(1):82-90. doi: 10.1016/j.canlet.2010.01.025. Epub 2010 Feb 13. Cancer Lett. 2010. PMID: 20153923
-
Methylation-acetylation interplay activates p53 in response to DNA damage.Mol Cell Biol. 2007 Oct;27(19):6756-69. doi: 10.1128/MCB.00460-07. Epub 2007 Jul 23. Mol Cell Biol. 2007. PMID: 17646389 Free PMC article.
-
Proteasome inhibition up-regulates p53 and apoptosis-inducing factor in chondrocytes causing severe growth retardation in mice.Cancer Res. 2007 Oct 15;67(20):10078-86. doi: 10.1158/0008-5472.CAN-06-3982. Cancer Res. 2007. PMID: 17942942
-
Regulation of p53 responses by post-translational modifications.Cell Death Differ. 2003 Apr;10(4):400-3. doi: 10.1038/sj.cdd.4401182. Cell Death Differ. 2003. PMID: 12719715 Review. No abstract available.
-
Regulation of p53--insights into a complex process.Crit Rev Biochem Mol Biol. 2009 Nov-Dec;44(6):367-92. doi: 10.3109/10409230903401507. Crit Rev Biochem Mol Biol. 2009. PMID: 19929178 Review.
Cited by
-
Cholesterol Perturbation in Mice Results in p53 Degradation and Axonal Pathology through p38 MAPK and Mdm2 Activation.PLoS One. 2010 Apr 6;5(4):e9999. doi: 10.1371/journal.pone.0009999. PLoS One. 2010. PMID: 20386595 Free PMC article.
-
p53 Binds to estrogen receptor 1 promoter in human breast cancer cells.Pathol Oncol Res. 2012 Apr;18(2):169-75. doi: 10.1007/s12253-011-9423-6. Epub 2011 Jun 8. Pathol Oncol Res. 2012. PMID: 21655924
-
Interaction between transactivation domain of p53 and middle part of TBP-like protein (TLP) is involved in TLP-stimulated and p53-activated transcription from the p21 upstream promoter.PLoS One. 2014 Mar 3;9(3):e90190. doi: 10.1371/journal.pone.0090190. eCollection 2014. PLoS One. 2014. PMID: 24594805 Free PMC article.
-
Posttranslational regulation of Fas ligand function.Cell Commun Signal. 2008 Dec 29;6:11. doi: 10.1186/1478-811X-6-11. Cell Commun Signal. 2008. PMID: 19114018 Free PMC article.
-
Inhibition of p53 deSUMOylation exacerbates puromycin aminonucleoside-induced apoptosis in podocytes.Int J Mol Sci. 2014 Nov 18;15(11):21314-30. doi: 10.3390/ijms151121314. Int J Mol Sci. 2014. PMID: 25411797 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous